A Study for the Adjuvant Treatment of Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Nab paclitaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Docetaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Nab paclitaxel|DRUG: Cyclophosphamide
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University